Effective vancomycin concentrations in children: a cross-sectional study.

Area of Science:

• Pharmacology
• Microbiology
• Pediatrics

Background:

• Vancomycin is crucial for treating serious Gram-positive bacterial infections.
• Optimizing vancomycin therapy in pediatric populations is challenging due to pharmacokinetic variability.
• Establishing appropriate dosing regimens is essential for achieving therapeutic efficacy and minimizing resistance.

Purpose of the Study:

• To evaluate the microbiological effectiveness of vancomycin in pediatric patients.
• To correlate vancomycin pharmacokinetics/pharmacodynamics (PK/PD) with treatment outcomes.
• To propose optimized vancomycin dosing strategies for children.

Main Methods:

• An observational, cross-sectional study was conducted in a pediatric hospital.
• Included were pediatric patients aged 2 to 12 years (excluding burn patients and those on renal replacement therapy).
• Blood samples were collected for pharmacokinetic analysis to determine vancomycin concentrations.

Main Results:

• Ten pediatric patients were analyzed (median age 5.5 years, median weight 21kg).
• Only one patient achieved the target trough concentration range of 10-15 µg/mL.
• The study highlighted suboptimal vancomycin exposure in the studied pediatric cohort.

Conclusions:

• Empirical vancomycin use in this pediatric cohort failed to reach the desired pharmacokinetic/pharmacodynamic target.
• The minimum inhibitory concentration (MIC) target of 1 µg/mL was not consistently achieved.
• Current dosing strategies may require adjustment to improve vancomycin efficacy in children.